(Q33936578)

English

Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bodsworth NJ

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Crooks RJ

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Borelli S

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Vejlsgaard G

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Paavonen J

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Worm AM

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Uexkull N

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Esmann J

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Strand A

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ingamells AJ

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gibb A

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Genitourinary medicine

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

110-116

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Safety of acyclovir: a summary of the first 10 years experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Acyclovir in first attacks of genital herpes and prevention of recurrences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Episodic acyclovir therapy to abort recurrent attacks of genital herpes simplex infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Acyclovir: A Decade Later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

28 July 2018

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195783

29 October 2018

Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9215092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9215092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recurrent genital herpes simplex infections with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/9215092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral acyclovir for episodic treatment of recurrent genital herpes. Efficacy and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/9215092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Episodic twice-daily treatment for recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9215092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9215092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9215092

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33936578&oldid=1620538843"